|
US20160279239A1
(en)
|
2011-05-02 |
2016-09-29 |
Immunomedics, Inc. |
Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
|
|
US8658773B2
(en)
|
2011-05-02 |
2014-02-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
TW200530269A
(en)
|
2003-12-12 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Anti-Mpl antibodies
|
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
|
JP5057967B2
(ja)
|
2005-03-31 |
2012-10-24 |
中外製薬株式会社 |
ｓｃ（Ｆｖ）２構造異性体
|
|
CA2611726C
(en)
|
2005-06-10 |
2017-07-11 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical compositions containing sc(fv)2
|
|
US8691224B2
(en)
|
2005-11-30 |
2014-04-08 |
Abbvie Inc. |
Anti-Aβ globulomer 5F7 antibodies
|
|
HRP20140240T4
(hr)
|
2005-11-30 |
2017-02-24 |
Abbvie Inc. |
Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
|
|
MY155286A
(en)
*
|
2005-12-12 |
2015-09-30 |
Hoffmann La Roche |
Antibodies against amyloid beta 4 with glycosylated in the variable region
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
AU2008311367B2
(en)
|
2007-10-05 |
2014-11-13 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
|
WO2009113083A1
(en)
|
2008-03-14 |
2009-09-17 |
Biocon Limited |
A monoclonal antibody and a method thereof
|
|
WO2009155513A2
(en)
*
|
2008-06-20 |
2009-12-23 |
Novartis Ag |
Immunoglobulins with reduced aggregation
|
|
ES2531385T3
(es)
*
|
2008-09-19 |
2015-03-13 |
Hoffmann La Roche |
Formulación que comprende un anticuerpo contra la selectina P
|
|
BRPI0919879A2
(pt)
|
2008-10-29 |
2016-02-16 |
Wyeth Llc |
métodos para purificação de moléculas de ligação a antígeno de domínio único
|
|
CA2738243C
(en)
|
2008-10-29 |
2020-09-29 |
Wyeth Llc |
Formulations of single domain antigen binding molecules
|
|
MX2011005051A
(es)
*
|
2008-11-17 |
2011-06-01 |
Genentech Inc |
Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas.
|
|
EP2196476A1
(en)
*
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
WO2010069858A1
(en)
*
|
2008-12-19 |
2010-06-24 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition
|
|
WO2010100179A2
(en)
*
|
2009-03-05 |
2010-09-10 |
Novartis Ag |
Self-forming gel system for sustained drug delivery
|
|
EP2501408B1
(en)
*
|
2009-11-20 |
2020-05-27 |
Biocon Limited |
Formulations of antibody
|
|
BR112012013148A2
(pt)
*
|
2009-12-29 |
2017-03-21 |
F Hoffmann - La Roche Ag |
formulação farmacêutica e uso
|
|
AR080428A1
(es)
|
2010-01-20 |
2012-04-11 |
Chugai Pharmaceutical Co Ltd |
Formulaciones liquidas estabilizadas contentivas de anticuerpos
|
|
EP3409289B1
(en)
|
2010-02-26 |
2020-09-30 |
Novo Nordisk A/S |
Stable antibody containing compositions
|
|
PT3345615T
(pt)
|
2010-03-01 |
2020-01-17 |
Bayer Healthcare Llc |
Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi)
|
|
NZ601117A
(en)
|
2010-03-03 |
2014-06-27 |
Boehringer Ingelheim Int |
Biparatopic abeta binding polypeptides
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
RU2012153786A
(ru)
|
2010-05-28 |
2014-07-10 |
Ново Нордиск А/С |
Стабильные многодозовые композиции, содержащие антитело и консервант
|
|
EP2598882B1
(en)
|
2010-07-30 |
2017-07-26 |
AC Immune S.A. |
Safe and functional humanized antibodies for use in treating an amyloidosis
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
WO2012028683A1
(en)
*
|
2010-09-02 |
2012-03-08 |
Novartis Ag |
Antibody gel system for sustained drug delivery
|
|
MX367097B
(es)
*
|
2011-05-02 |
2019-08-05 |
Millennium Pharm Inc |
FORMULACION PARA ANTICUERPO ANTI-A4ß7.
|
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
|
CN107233569B
(zh)
|
2011-10-25 |
2021-08-31 |
普罗西纳生物科学有限公司 |
抗体制剂和方法
|
|
RS54644B1
(sr)
*
|
2012-03-08 |
2016-08-31 |
F. Hoffmann-La Roche Ag |
Formulacija abeta antitela
|
|
EP4527855A3
(en)
*
|
2012-03-26 |
2025-06-11 |
Sanofi |
Stable igg4 based binding agent formulations
|
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
|
US20130281355A1
(en)
|
2012-04-24 |
2013-10-24 |
Genentech, Inc. |
Cell culture compositions and methods for polypeptide production
|
|
US8883979B2
(en)
*
|
2012-08-31 |
2014-11-11 |
Bayer Healthcare Llc |
Anti-prolactin receptor antibody formulations
|
|
US8613919B1
(en)
|
2012-08-31 |
2013-12-24 |
Bayer Healthcare, Llc |
High concentration antibody and protein formulations
|
|
US9592297B2
(en)
*
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
|
TW201513882A
(zh)
*
|
2013-03-15 |
2015-04-16 |
Bayer Healthcare Llc |
抗－催乳激素受體抗體調配物
|
|
EP3024485B1
(en)
|
2013-07-23 |
2020-11-18 |
Biocon Limited |
Use of a cd6 binding partner and method based thereon
|
|
CN107108715A
(zh)
|
2014-10-24 |
2017-08-29 |
默沙东公司 |
胰高血糖素和glp‑1受体的共激动剂
|
|
JP6781508B2
(ja)
*
|
2014-11-18 |
2020-11-04 |
塩野義製薬株式会社 |
安定化されたペプチド組成物
|
|
AR103173A1
(es)
|
2014-12-22 |
2017-04-19 |
Novarits Ag |
Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
|
|
CN104946616A
(zh)
*
|
2015-05-12 |
2015-09-30 |
骏实生物科技(上海)有限公司 |
一种用于体外诊断试剂的通用固体稳定剂及其使用方法
|
|
AR104847A1
(es)
*
|
2015-06-17 |
2017-08-16 |
Lilly Co Eli |
Formulación de anticuerpo anti-cgrp
|
|
HUE057952T2
(hu)
|
2015-06-24 |
2022-06-28 |
Hoffmann La Roche |
Anti-transzferrin receptor antitestek testreszabott affinitással
|
|
RS64263B1
(sr)
*
|
2015-08-19 |
2023-07-31 |
Astrazeneca Ab |
Stabilna anti-ifnar1 formulacija
|
|
MX2018003298A
(es)
*
|
2015-09-22 |
2018-06-20 |
Pfizer |
Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo.
|
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
|
TWI873952B
(zh)
|
2015-10-02 |
2025-02-21 |
瑞士商赫孚孟拉羅股份公司 |
雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
|
|
CN106620691B
(zh)
*
|
2015-11-04 |
2020-08-21 |
信达生物制药(苏州)有限公司 |
一种重组全人源抗ctla-4单克隆抗体制剂及其应用
|
|
CN115400220A
(zh)
|
2015-12-30 |
2022-11-29 |
豪夫迈·罗氏有限公司 |
减少聚山梨酯降解的制剂
|
|
CN106199007B
(zh)
*
|
2016-08-03 |
2017-04-05 |
烟台普罗吉生物科技发展有限公司 |
蛋白保护剂
|
|
ES2991182T3
(es)
|
2016-10-21 |
2024-12-02 |
Biocon Ltd |
Un anticuerpo monoclonal y un método de uso para el tratamiento del lupus
|
|
CN106913869B
(zh)
*
|
2017-03-17 |
2020-07-28 |
信达生物制药(苏州)有限公司 |
一种抗ctla-4单克隆抗体制剂及其应用
|
|
US10799597B2
(en)
|
2017-04-03 |
2020-10-13 |
Immunomedics, Inc. |
Subcutaneous administration of antibody-drug conjugates for cancer therapy
|
|
CN118370815A
(zh)
*
|
2017-08-22 |
2024-07-23 |
渤健马萨诸塞州股份有限公司 |
含有抗β淀粉样蛋白抗体的药物组合物
|
|
CN108373494A
(zh)
*
|
2018-02-27 |
2018-08-07 |
武汉伊艾博科技有限公司 |
一种防止重组蛋白质降解的保护技术
|
|
CN120241997A
(zh)
|
2019-02-18 |
2025-07-04 |
伊莱利利公司 |
治疗性抗体制剂
|
|
CN112618482A
(zh)
*
|
2019-09-24 |
2021-04-09 |
江苏恒瑞医药股份有限公司 |
新型蛋白制剂
|
|
CN112741804A
(zh)
*
|
2019-10-31 |
2021-05-04 |
上海君实生物医药科技股份有限公司 |
含有抗pd-l1抗体的稳定制剂
|
|
CN113116812A
(zh)
*
|
2019-12-30 |
2021-07-16 |
百奥泰生物制药股份有限公司 |
含抗Trop2抗体-药物偶联物的制剂及其制备方法和应用
|
|
EP4159236A4
(en)
|
2020-05-29 |
2024-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing formulation
|
|
US20230365667A1
(en)
*
|
2020-09-30 |
2023-11-16 |
Merck Sharp & Dohme Llc |
Binding proteins and antigen binding fragments thereof that bind abeta
|
|
AU2024283314A1
(en)
|
2023-05-31 |
2025-11-13 |
F. Hoffmann-La Roche Ag |
Therapeutic use of bispecific anti-abeta/tfr antibodies
|
|
CN117088974B
(zh)
*
|
2023-08-14 |
2024-02-13 |
武汉健昊生物科技有限公司 |
一种抗体保存液
|